CRVO (CervoMed Corporation) Bozor qiymatining balans qiymatiga nisbati
CervoMed Inc. (CRVO) raqobatchilarsiz bo'lgan tor doiradagi bozorda, jumladan, Lyui tanachalari dementsiyasiga qarshi miya degeneratsiyasi bilan kurashish uchun innovatsion terapiyalarni ishlab chiqmoqda. Biroq, biznes o'zining asosiy dori vositasi uchun klinik sinovlarning muvaffaqiyatsizligi va mablag'lar yetishmasligi xavfga duch kelmoqda, bu esa aksiyalar narxi tarixida 1.30 darajasida aks etgan. Bunday xizmatlarga bo'lgan talab makroiqtisodiy omillardan mustaqil bo'lib, faqatgina tartibga soluvchi organlarning qarorlariga bog'liqdir.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_CRVO_-_CervoMed-Inc._-_Capitalization-to-Book-Value-Ratio "CRVO CervoMed Bozor kapitallashuvining balans qiymatiga nisbati (21.02.2024 - 29.10.2026) | 👁️GURU.Markets👁️")
CervoMed, Inc. (CRVO) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati CervoMed Inc.|CRVO - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati CervoMed Inc|CRVO - Kompaniyaning umumiy yig'indi qarzi|Balans kapitallashuviga qarzlar CervoMed Inc|CRVO - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari CervoMed
Kompaniyaning dastlabki tahlili:CervoMed Inc., CRVO
Ko'rsatkich bozor kapitalizatsiyasining sof aktivlar qiymatiga nisbati sifatida hisoblanadi. Ushbu metrika investorlarning biznesning moddiy aktivlari uchun qanchalik ortiqcha to'lov qilayotganini aniqlaydi va spekulyativ xavf darajasini aks ettiradi. CervoMed Inc. (CRVO) uchun yuqori baholash demensiya terapiyasiga bo'lgan doimiy talab kutilayotganligi bilan bog'liq. Dorining patent muddati kelgusidagi qiymatni yaratadi, biroq bu balans hisobotida aks etmaydi. Joriy bozor qiymatining buxgalteriya qiymatiga nisbatini tahlil qilish orqali investitsiyaning xavfsizlik zaxirasini baholash mumkin.
Raqobatchilar tahlili
Bozor qiymatining balans qiymatiga nisbati BIIB|NBIX (neurocrine.com) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited (RGC)|Kapitallashuvning balans qiymatiga nisbati Axsome|ACADIA Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Xenon Corp XENE|Kapitallashuvning sof aktivlarga nisbati VKTX (Viking Therapeutics)|supernus.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Catalyst Pharmaceuticals, Inc. (CPRX)|DNLI: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati HRMY|Biohaven Corp (BHVN) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati AMLX|Kapitallashuvning sof aktivlarga nisbati trevitherapeutics.com|Praxis Precision Medicines, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti AVXL (Anavex)|Bozor qiymatining balans qiymatiga nisbati CeriBell Corp|PRTA - Balans qiymatiga nisbatan bozor qiymati|ALEC - Kapitallashuvning sof aktivlarga nisbati|ANNX: Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati OMER|NGNE (Neurogene Inc) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati ACIU|Kapitallashuvning sof aktivlarga nisbati Voyager Corp|Neumora Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti scilexholding.com (SCLX)|TVGN - Bozor kapitallashuvining balans qiymatiga nisbati|ACOG - Kapitallashuvning balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Cognition Therapeutics, Inc. (CGTX)|IKT - Balans qiymatiga nisbatan bozor qiymati|Cassava Sciences, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|ASRT (Assertio) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Coya Therapeutics Inc (COYA)|Kapitallashuvning balans qiymatiga nisbati VistaGen Therapeutics Inc|Bozor kapitallashuvining balans qiymatiga nisbati OVID (Ovid Therapeutics Inc.)|Kapitallashuvning sof aktivlarga nisbati Acumen Pharmaceuticals, Inc ABOS|Kapitallashuvning sof aktivlarga nisbati ATHE|Balans qiymatiga nisbatan bozor kapitallashuvi Clene Inc CLNN|PEPG: Bozor kapitallashuvining balans qiymatiga nisbati|JUNS: Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati Relmada RLMD|Balans qiymatiga nisbatan bozor qiymati Annovis Bio Corporation|Kapitallashuvning sof aktivlarga nisbati Grace Therapeutics Inc|Bozor qiymatining balans qiymatiga nisbati AIFF|Klotho Neurosciences Inc - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti NRSN (neurosense-tx.com)|RVPH - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati MetaVia Inc. MTVA|NRXS (NeurAxis, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Helius Medical (HSDT) - Bozor qiymatining balans qiymatiga koeffitsiyenti|PASG: Kapitallashuvning sof aktivlarga nisbati|NEUP (Neuphoria Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|NERV - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ATHA|Addex Therapeutics - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti alzamend.com (ALZN)|Cyclerion Therapeutics, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Protagenic Therapeutics Inc. PTIX|KTTA (Pasithea) - Bozor kapitallashuvining balans qiymatiga nisbati|CRGT: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Avenue Therapeutics ATXI|Balans qiymatiga nisbatan bozor qiymati brainstorm-cell.com|Kapitallashuvning sof aktivlarga nisbati Cara Therapeutics|Bozor qiymatining balans qiymatiga nisbati CHRO|Eliem Therapeutics - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti ITCI (intracellulartherapies.com)|Longboard Pharmaceuticals - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati marinuspharma.com MRNS|NKGN (NKGen Biotech) - Bozor kapitallashuvining balans qiymatiga nisbati|NRBO - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati Sage Therapeutics, Inc|Kapitallashuvning balans qiymatiga nisbati Synaptogenix, Inc|TRVN - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Vigil Neuro|WENA (Anew Medical, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi CERE (Cerevel Therapeutics Inc)